1. Home
  2. Labeler Index
  3. Auromedics Pharma Llc
  4. 55150-270
  5. Product Images: Cyclophosphamide

Product Images Cyclophosphamide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Cyclophosphamide NDC 55150-270 by Auromedics Pharma Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL- 500 mg per 2.5 mL (200 mg per mL) - Container Label - cyclophosphamide fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL- 500 mg per 2.5 mL (200 mg per mL) - Container Label - cyclophosphamide fig1

This is a prescription-only injection medication containing Cyclophosphamide (200mg) and citric acid (4m) in each 2.5mL vial. It is a sterile, nonpyrogenic solution meant for intravenous infusion only. The vial must be stored refrigerated between 2-8°C (36-46°F) and any unused portion must be discarded. This medication is hazardous and must be handled with care. The recommended injection dosage should be obtained through the prescribing information. The label indicates that it was distributed by PuroMedics Pharma LLC in East Windsor, NJ, and produced in India by Auromedics.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-500 mg per 2.5 mL (200 mg per mL) - Container-Carton (1 Vial) - cyclophosphamide fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-500 mg per 2.5 mL (200 mg per mL) - Container-Carton (1 Vial) - cyclophosphamide fig2

This is a description of a hazardous drug called Cyclophosphamide injection. It is available in a 2.5 ml vial and should be used for intravenous infusion after dilution. Each mL of Cyclophosphamide contains 200 mg of Cyclophosphamide and 4mg citric acid. The recommended dosage should be determined by a prescribing physician who has a thorough knowledge of the dose and indications. The vial should be stored refrigerated at 2°C to 8°C. The manufacturer of this injection is Aurobindo Pharma LLC.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL- 1 g per 5 mL (200 mg per mL) - Container Label - cyclophosphamide fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL- 1 g per 5 mL (200 mg per mL) - Container Label - cyclophosphamide fig3

This is a prescription drug called Cyclophosphamide. It is a sterile and nonpyrogenic liquid that contains 200mg Cyclophosphamide per mL along with other chemicals. It is to be given through intravenous infusion, and the recommended dosage should be obtained from the prescribing information. The drug should be kept at a cool temperature, and the unused portion of a single-dose vial should be discarded safely as it is a hazardous agent. The drug is distributed by AuroMedics Pharma LLC.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-1 g per 5 mL (200 mg per mL) - Container-Carton (1 Vial) - cyclophosphamide fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-1 g per 5 mL (200 mg per mL) - Container-Carton (1 Vial) - cyclophosphamide fig4

This is a prescription drug called Cyclophosphamide, used for intravenous infusion after dilution. Each mL contains 200 mg of Cyclophosphamide and 4 mg of citric acid dissolved in dehydrated alcohol. It is a hazardous agent and should be used only after consulting with a doctor who has thorough knowledge of its dose, indications, and toxicity as described in the prescribing information. The vial stopper is not made with natural rubber latex. The drug should be stored refrigerated at 2°C to 8°C. The text also includes the drug's NDC number and the manufacturer's information.*

cyclophosphamide-structure - cyclophosphamide str

cyclophosphamide-structure - cyclophosphamide str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.